Platelet-Free Plasma (PFP) Injection: Not a Clinical Therapeutic Intervention
Platelet-free plasma (PFP) is not a therapeutic injection used in clinical medicine—it is a laboratory preparation technique used to remove platelets from blood samples for research purposes, particularly for studying extracellular vesicles and biomarkers. You appear to be confusing this with platelet-rich plasma (PRP) injections, which are an entirely different entity.
What PFP Actually Is
PFP refers to plasma that has undergone centrifugation to remove essentially all platelets, typically used in laboratory settings for:
- Research on extracellular vesicles 1
- Biomarker analysis where platelet contamination would confound results 2
- Pyrophosphate assays where platelet-derived PPi would falsely elevate measurements 3
Preparation Method
PFP is prepared by double centrifugation of anticoagulated blood 1:
- First spin: 2,500g for 15 minutes to remove red cells, white cells, and most platelets
- Second spin: Same conditions using a clean tube to remove residual platelets
- Alternative single-step protocol: 5,000g for 20 minutes 2
The goal is to achieve essentially zero residual platelets (typically <1,000/μL) 1, 2.
What You Likely Mean: Platelet-Rich Plasma (PRP)
If you're asking about PRP injections for musculoskeletal conditions:
Strong Recommendation Against PRP for Osteoarthritis
PRP injections are strongly recommended against for knee and hip osteoarthritis 4. The 2019 American College of Rheumatology/Arthritis Foundation guidelines explicitly state this due to:
- Heterogeneity and lack of standardization in PRP preparations
- Inconsistent techniques making it unclear what is actually being injected
- Insufficient evidence of benefit relative to known risks
Key Contraindications for PRP (If Used Despite Guidelines)
Based on 2025 GRIIP consensus 5, PRP should be avoided in:
Infectious diseases:
- Active viral or bacterial infections
- Patients on immunosuppressive therapy
- Active dental infections
Oncologic conditions:
- Local tumors at injection site
- Active cancer (not in remission)
Hematologic diseases:
- Severe cytopenia
- Active hemopathy
- Unstabilized monoclonal gammopathy
Critical Distinction
Do not confuse laboratory PFP preparation with clinical PRP therapy. PFP removes platelets for research; PRP concentrates platelets for injection—they are opposite processes serving completely different purposes.